Global Laxatives Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Hyperosmotic, Bulk-Forming, Stool Softeners, Lubricants, Stimulants, and Other

By Administration;

Oral and Rectal

By Indication;

Chronic Constipation, Irritable Bowel Syndrome, and Others

By Dosage Form;

Tablets & Capsules, Powders, Liquids, and Suppositories

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn674846840 Published Date: May, 2025 Updated Date: June, 2025

Laxatives Market Overview

Laxatives Market (USD Million)

Laxatives Market was valued at USD 7,208.57 million in the year 2024, the. The size of this market is expected to increase to USD 10,696.68 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.8%.


Global Laxatives Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 5.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.8 %
Market Size (2024)USD 7,208.57 Million
Market Size (2031)USD 10,696.68 Million
Market ConcentrationMedium
Report Pages368
7,208.57
2024
10,696.68
2031

Major Players

  • Bayer AG
  • Boehringer Ingelheim Pharmaceuticals Inc.
  • Eskag Pharma Pvt. Ltd.
  • GlaxoSmithKline Plc
  • Procter & Gamble Company
  • Purdue Pharma L.P.
  • Mallinckrodt Pharmaceuticals
  • Abbott Laboratories

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Laxatives Market

Fragmented - Highly competitive market without dominant players


The laxatives market is experiencing significant growth, fueled by the increasing prevalence of digestive health issues and the growing demand for effective solutions to alleviate constipation. It is estimated that around 20% of the global population suffers from chronic constipation, making laxatives an essential part of healthcare routines. These treatments offer relief for both acute and long-term digestive concerns.

Rising Awareness of Digestive Wellness
As awareness of gastrointestinal health expands, more people are turning to over-the-counter laxatives to manage constipation. With an emphasis on preventive health and self-medication, the market is witnessing a shift toward products that offer convenience and effectiveness. Today, nearly 40% of consumers are choosing natural or alternative laxative options, signaling a broadening of available product types.

Innovations in Laxative Formulations
The development of advanced laxative formulations has enhanced both the safety and effectiveness of these products. Slow-release formulations and prebiotic-based solutions are gaining traction, contributing to a 15% increase in market growth. These innovations provide consumers with longer-lasting relief and fewer side effects, which is driving their popularity in the market.

Aging Population Fuels Market Expansion
As the global population ages, the demand for laxatives is increasing, particularly among older adults who are more prone to constipation due to factors like lower physical activity and polypharmacy. Approximately 25% of elderly individuals rely on laxatives regularly, creating a significant market opportunity for companies focusing on digestive health solutions for this demographic.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Administration
    3. Market Snapshot, By Indication
    4. Market Snapshot, By Dosage Form
    5. Market Snapshot, By Region
  4. Laxatives Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of chronic constipation disorders
        2. Growing aging population with digestive issues
        3. Rising demand for over-the-counter laxatives
        4. Unhealthy dietary habits fueling bowel problems
      2. Restraints
        1. Adverse effects from prolonged laxative use
        2. Availability of natural and home remedies
        3. Limited awareness in low-income regions
        4. Strict regulations on product labeling
      3. Opportunities
        1. Product innovation in herbal laxatives
        2. Expansion into untapped rural markets
        3. Rising health awareness among consumers
        4. E-commerce growth boosting product accessibility
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Laxatives Market, By Type, 2021 - 2031 (USD Million)
      1. Hyperosmotic
      2. Bulk-Forming
      3. Stool Softeners
      4. Lubricants
      5. Stimulants
      6. Other
    2. Laxatives Market, By Administration, 2021 - 2031 (USD Million)
      1. Oral
      2. Rectal
    3. Laxatives Market, By Indication, 2021 - 2031 (USD Million)
      1. Chronic Constipation
      2. Irritable Bowel Syndrome
      3. Others
    4. Laxatives Market, By Dosage Form, 2021 - 2031 (USD Million)
      1. Tablets & Capsules
      2. Powders
      3. Liquids
      4. Suppositories
    5. Laxatives Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Pfizer Inc.
      2. TCI Chemicals Pvt. Ltd.
      3. Adwia Pharmaceuticals Co.
      4. 3M
      5. Bausch and Lomb Incorporated
      6. Rebion
      7. Vivid Vision, Inc.
      8. Johnson and Johnson Services, Inc.
  7. Analyst Views
  8. Future Outlook of the Market